Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):104–117.
   Web of Science ®Google Scholar
• Lin KY, Kraus WL. PARP inhibitors for cancer therapy. Cell. 2017;169(2):183. doi:10.1016/j.cell.2017.03.03428388401
   PubMed Web of Science ®Google Scholar
• Simona M, Julien N, Patrick CJNM. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991–1003. doi:10.1038/nmat377624150417
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao Q, Han N, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015;11(2):313–327. doi:10.1016/j.nano.2014.09.01425461284
   PubMed Web of Science ®Google Scholar
• Maeding N, Verwanger T, Krammer B. Boosting tumor-specific immunity using PDT. Cancers. 2016;8(10):91. doi:10.3390/cancers8100091
   PubMed Web of Science ®Google Scholar
• Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006;6(7):535–545. doi:10.1038/nrc189416794636
   PubMed Web of Science ®Google Scholar
• Chilakamarthi U, Giribabu L. Photodynamic therapy: past, present and future. Chem Rec. 2017;17(8):775–802. doi:10.1002/tcr.20160012128042681
   PubMed Web of Science ®Google Scholar
• Straten D, Mashayekhi V, Bruijn HS, Oliveira S, Robinson D. Oncologic photodynamic therapy: basic principles, current clinical status and future directions. Cancers. 2017;9(12):19. doi:10.3390/cancers9020019
   PubMedGoogle Scholar
• Dabrowski JM. Reactive oxygen species in photodynamic therapy: mechanisms of their generation and potentiation. Adv Inorg Chem. 2017;70:343–394.
   Web of Science ®Google Scholar
• Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38(8):2628–2635.667856
   PubMed Web of Science ®Google Scholar
• Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. 2016;473(4):347–364. doi:10.1042/BJ2015094226862179
   PubMed Web of Science ®Google Scholar
• Ren H, Liu J, Su F, et al. Relighting photosensitizers by synergistic integration of albumin and perfluorocarbon for enhanced photodynamic therapy. ACS Appl Mater Interfaces. 2017;9(4):3463–3473. doi:10.1021/acsami.6b1488528067039
   PubMedGoogle Scholar
• Voon SH, Kiew LV, Lee HB, et al. In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy. Small. 2014;10(24):4993–5013. doi:10.1002/smll.20140141625164105
   PubMedGoogle Scholar
• Espinosa-Cano E, Palao-Suay R, Aguilar MR, et al. Polymeric nanoparticles for cancer therapy and bioimaging. J Drug Target. 2018;16(2):108–123.
   Google Scholar
• Qin SY, Zhang AQ, Cheng SX, Rong L, Zhang XZ. Drug self-delivery systems for cancer therapy. Biomaterials. 2017;112:234–247. doi:10.1016/j.biomaterials.2016.10.01627768976
   PubMed Web of Science ®Google Scholar
• Huo M, Wang L, Chen Y, Shi J. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat Commun. 2017;8(1):357. doi:10.1038/s41467-017-00424-828842577
   PubMedGoogle Scholar
• Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev. 2012;41(7):2885–2911. doi:10.1039/c2cs15260f22286540
   PubMed Web of Science ®Google Scholar
• Elizabeth H, Gang ZJN. Cancer nanomedicine: addressing the dark side of the enhanced permeability and retention effect. Nanomedicine. 2015;10(13):1993–1995. doi:10.2217/nnm.15.8626096565
   PubMedGoogle Scholar
• Uma P, Hiroshi M, Jain RK, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013;73(8):2412–2417. doi:10.1158/0008-5472.CAN-12-456123423979
   PubMedGoogle Scholar
• Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today. 2005;10(21):1451–1458. doi:10.1016/S1359-6446(05)03575-016243265
   PubMed Web of Science ®Google Scholar
• Verhoef JJ, Anchordoquy TJ. Questioning the use of PEGylation for drug delivery. Drug Deliv Transl Res. 2013;3(6):499–503.24932437
   PubMed Web of Science ®Google Scholar
• Yu G, Zhu B, Shao L, et al. Host-guest complexation-mediated codelivery of anticancer drug and photosensitizer for cancer photochemotherapy. P Natl Acad Sci USA. 2019;116(14):6618–6623. doi:10.1073/pnas.1902029116
   PubMed Web of Science ®Google Scholar
• Yu G, Cen TY, He Z, et al. Porphyrin nanocage-embedded single-molecular nanoparticles for cancer nanotheranostics. Angew Chem Int Edit. 2019;58(26):8799–8803. doi:10.1002/anie.201903277
   PubMed Web of Science ®Google Scholar
• Guo B, Zhao J, Wu C, et al. One-pot synthesis of polypyrrole nanoparticles with tunable photothermal conversion and drug loading capacity. Colloid Surface B. 2019;177:346–355. doi:10.1016/j.colsurfb.2019.02.016
   PubMed Web of Science ®Google Scholar
• Wu C, Wang S, Zhao J, et al. Biodegradable Fe(III)@WS2-PVP nanocapsules for redox reaction and TME-enhanced nanocatalytic, photothermal, and chemotherapy. Adv Funct Mater. 2019;29(26):1901722. doi:10.1002/adfm.201901722
   Web of Science ®Google Scholar
• Lynge ME, Rebecca VDW, Almar P, Brigitte SDJN. Polydopamine–a nature-inspired polymer coating for biomedical science. Nanoscale. 2011;3(12):4916–4928. doi:10.1039/c1nr10969c22024699
   PubMed Web of Science ®Google Scholar
• Yanlan L, Kelong A, Lehui LJCR. Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. Chem Rev. 2014;114(9):5057–5115. doi:10.1021/cr400407a24517847
   PubMedGoogle Scholar
• Dong ZL, Gong H, Gao M, et al. Polydopamine nanoparticles as a versatile molecular loading platform to enable imaging-guided cancer combination therapy. Theranostics. 2016;6(7):1031–1042. doi:10.7150/thno.1443127217836
   PubMed Web of Science ®Google Scholar
• Yan SF, Song XR, Liu Y, et al. An efficient synergistic cancer therapy by integrating cell cycle inhibitor and photosensitizer into polydopamine nanoparticles. J Mater Chem B. 2018;6(17):2620–2629. doi:10.1039/C8TB00076J
   PubMed Web of Science ®Google Scholar
• Wang S, Zhao X, Wang S, Qian J, He S. Biologically inspired polydopamine capped gold nanorods for drug delivery and light-mediated cancer therapy. ACS Appl Mater Interfaces. 2016;8(37):24368–24384. doi:10.1021/acsami.6b0590727564325
   PubMedGoogle Scholar
• Chen W, Qin M, Chen X, Wang Q, Zhang Z, Sun XJT. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al2O3nanoparticles. Theranostics. 2018;8(8):2229–2241. doi:10.7150/thno.2407329721075
   PubMed Web of Science ®Google Scholar
• Lin LS, Cong ZX, Cao JB, et al. Multifunctional Fe3O4@Polydopamine Coreâ-shell nanocomposites for intracellular mRNA detection and imaging-guided photothermal therapy. ACS Nano. 2014;8(4):3876. doi:10.1021/nn500722y24654734
   PubMedGoogle Scholar
• Wang C, Xu H, Liang C, et al. Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano. 2013;7(8):6782–6795. doi:10.1021/nn401717923822176
   PubMed Web of Science ®Google Scholar
• Ding L, Zhu X, Wang Y, et al. Intracellular fate of nanoparticles with polydopamine surface engineering and a novel strategy for exocytosis-inhibiting, lysosome impairment-based cancer therapy. Nano Lett. 2017;17(11):6790–6801. doi:10.1021/acs.nanolett.7b0302129058908
   PubMedGoogle Scholar
• Ge R, Lin M, Li X, et al. Cu(2+)-loaded polydopamine nanoparticles for magnetic resonance imaging-guided pH- and near-infrared-light-stimulated thermochemotherapy. ACS Appl Mater Interfaces. 2017;9(23):19706–19716. doi:10.1021/acsami.7b0558328553876
   PubMedGoogle Scholar
• Kurahara H, Takao S, Kuwahata T, et al. Clinical significance of folate receptor beta-expressing tumor-associated macrophages in pancreatic cancer. Ann Surg Oncol. 2012;19(7):2264–2271. doi:10.1245/s10434-012-2263-022350599
   PubMedGoogle Scholar
• Teng L, Xie J, Teng L, Lee RJ. Clinical translation of folate receptor-targeted therapeutics. Expert Opin Drug Del. 2012;9(8):901–908. doi:10.1517/17425247.2012.694863
   PubMed Web of Science ®Google Scholar
• Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer. 2015;73(9):2432–2443. doi:10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
   Google Scholar
• Assaraf YG, Leamon CP, Reddy JA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Update. 2014;17(4–6):89–95. doi:10.1016/j.drup.2014.10.002
   PubMed Web of Science ®Google Scholar
• Ren D, Kratz F, Wang SW. Engineered drug-protein nanoparticle complexes for folate receptor targeting. Biochem Eng J. 2014;89:33–41. doi:10.1016/j.bej.2013.09.00825018664
   PubMedGoogle Scholar
• Zheng M, Gong P, Zheng C, et al. Lipid-polymer nanoparticles for folate-receptor targeting delivery of doxorubicin. J Nanosci Nanotechnol. 2015;15(7):4792–4798. doi:10.1166/jnn.2015.960426373039
   PubMed Web of Science ®Google Scholar
• Muller C, Schibli R. Prospects in folate receptor-targeted radionuclide therapy. Front Oncol. 2013;3:249. doi:10.3389/fonc.2013.0024924069581
   PubMedGoogle Scholar
• Annette K, Laura W, Laura H, et al. Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum. Nanomedicine. 2014;10(7):1421–1431. doi:10.1016/j.nano.2014.01.00624491397
   PubMedGoogle Scholar
• Zhang H, Li JC, Hu Y, Shen MW, Shi XY, Zhang GF. Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer. J Ovarian Res. 2016;9(1):19. doi:10.1186/s13048-016-0230-227025582
   PubMed Web of Science ®Google Scholar
• Shakeri-Zadeh A, Kamrava SK, Farhadi M, Hajikarimi Z, Maleki S, Ahmadi A. A scientific paradigm for targeted nanophotothermolysis; the potential for nanosurgery of cancer. Laser Med Sci. 2014;29(2):847–853. doi:10.1007/s10103-013-1399-x
   PubMed Web of Science ®Google Scholar
• Beik J, Khademi S, Attaran N, et al. A nanotechnology-based strategy to increase the efficiency of cancer diagnosis and therapy: folate-conjugated gold nanoparticles. Curr Med Chem. 2017;24(39):4399–4416. doi:10.2174/092986732466617081015491728799495
   PubMed Web of Science ®Google Scholar
• Eyvazzadeh N, Shakeri-Zadeh A, Fekrazad R, Amini E, Ghaznavi H, Kamran Kamrava S. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer. Laser Med Sci. 2017;32(7):1469–1477. doi:10.1007/s10103-017-2267-x
   PubMed Web of Science ®Google Scholar
• Mirrahimi M, Hosseini V, Kamrava SK, et al. Selective heat generation in cancer cells using a combination of 808 nm laser irradiation and the folate-conjugated Fe2O3@Au nanocomplex. Artif Cell Nanomed B. 2018;46(sup1):241–253. doi:10.1080/21691401.2017.1420072
   PubMed Web of Science ®Google Scholar
• Neshastehriz A, Tabei M, Maleki S, Eynali S, Shakeri-Zadeh A. Photothermal therapy using folate conjugated gold nanoparticles enhances the effects of 6MV X-ray on mouth epidermal carcinoma cells. J Photoch Photobio B. 2017;172:52–60. doi:10.1016/j.jphotobiol.2017.05.012
   PubMed Web of Science ®Google Scholar
• Zeinizade E, Tabei M, Shakeri-Zadeh A, et al. Selective apoptosis induction in cancer cells using folate-conjugated gold nanoparticles and controlling the laser irradiation conditions. Artif Cell Nanomed B. 2018;46(sup1):1026–1038. doi:10.1080/21691401.2018.1443116
   PubMed Web of Science ®Google Scholar
• Movahedi MM, Mehdizadeh A, Koosha F, et al. Investigating the photo-thermo-radiosensitization effects of folate-conjugated gold nanorods on KB nasopharyngeal carcinoma cells. Photodiagn Photodyn. 2018;24:324–331. doi:10.1016/j.pdpdt.2018.10.016
   PubMed Web of Science ®Google Scholar
• Beik J, Jafariyan M, Montazerabadi A, et al. The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: radiation dose reduction and image contrast enhancement. Artif Cell Nanomed B. 2018;46(8):1993–2001.
   PubMed Web of Science ®Google Scholar
• Ghaznavi H, Hosseini-Nami S, Kamrava SK, et al. Folic acid conjugated PEG coated gold-iron oxide core-shell nanocomplex as a potential agent for targeted photothermal therapy of cancer. Artif Cell Nanomed B. 2018;46(8):1594–1604.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zheng K, Chen Z, et al. Rapid killing of bacteria by a new type of photosensitizer. Appl Microbiol Biotechnol. 2017;101(11):4691–4700. doi:10.1007/s00253-017-8133-828251266
   PubMedGoogle Scholar
• Yan SF, Chen JC, Cai LZ, et al. Phthalocyanine-based photosensitizer with tumor-pH-responsive properties for cancer theranostics. J Mater Chem B. 2018;6(38):6080–6088. doi:10.1039/C8TB01884G
   PubMed Web of Science ®Google Scholar
• Cheng W, Nie J, Xu L, et al. pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS Appl Mater Interfaces. 2017;9(22):18462–18473. doi:10.1021/acsami.7b0245728497681
   PubMed Web of Science ®Google Scholar
• Zhao J, Feng SS. Effects of PEG tethering chain length of vitamin E TPGS with a Herceptin-functionalized nanoparticle formulation for targeted delivery of anticancer drugs. Biomaterials. 2014;35(10):3340–3347. doi:10.1016/j.biomaterials.2014.01.00324461325
   PubMedGoogle Scholar
• Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005;5(7):526–542. doi:10.1038/nrc164916069816
   PubMed Web of Science ®Google Scholar
• Piscuoglio S, Ng CK, Murray MP, et al. The genomic landscape of male breast cancers. Clin Cancer Res. 2016;22(16):4045–4056. doi:10.1158/1078-0432.CCR-15-2840>26960396
   PubMed Web of Science ®Google Scholar